Heartburn is a normal consequence of pregnancy, occurring in nearly two-thirds of women. The predominant cause is a decrease in LES pressure caused by female sex hormones, especially progesterone. Serious reflux complications (i.e. oesophagitis) during pregnancy are uncommon; therefore upper endoscopy and other diagnostic tests are usually not needed. Symptomatic GERD during pregnancy should be managed with a step-up algorithm beginning with lifestyle modifications and dietary changes (Figure 1). Antacids or sucralfate are considered the first-line medical therapy. If symptoms persist, any of the H2RAs can be used. Proton-pump inhibitors are reserved for women with intractable symptoms or complicated reflux disease. All but omeprazole are FDA category B drugs during pregnancy. Most drugs are excreted in breast milk. Of the systemic agents, only the H2RAs, with the exception of nizatidine, are safe to use during lactation.
CLICK HERE for subscription information about this journal.
Thanks to Liz Koniz for excellent secretarial assistance.Funding information
No external funding was received for this study.
Correspondence to: Dr J.E. Richter, Department of Medicine, Temple University School of Medicine, 3401 North Broad Street, 800 Parkinson Pavilion, Philadelphia, PA 19140, USA. E-mail: firstname.lastname@example.org
Aliment Pharmacol Ther. 2005;22(9):749-757. © 2005 Blackwell Publishing
Cite this: Review Article: The Management of Heartburn in Pregnancy - Medscape - Nov 01, 2005.